Description

Memamed (memantine) Coated Tablets 10 mg. №30

Ingredients

Active ingredient: Memantine hydrochloride.
Other ingredients: Microcrystalline cellulose, colloidal anhydrous silica, talc, magnesium stearate, hypromellose, macrogol 400, titanium dioxide (E171).

Dosage

Recommended dosage: The usual starting dose is 5 mg once daily. The dose is then increased by 5 mg each week, up to a maximum of 20 mg per day, taken in divided doses.

Indications

Memamed (memantine) coated tablets are indicated for the treatment of moderate to severe Alzheimer’s disease.

Contraindications

Do not use Memamed (memantine) coated tablets if:

• You are allergic to memantine or any other ingredients in the product.
• You have severe renal impairment.
• You are pregnant or breastfeeding.

Directions

Take Memamed (memantine) coated tablets exactly as prescribed by your healthcare provider. Swallow the tablets whole with water, with or without food.

Scientific Evidence

Studies have shown that memantine, the active ingredient in Memamed tablets, can help improve cognitive function and slow the progression of Alzheimer’s disease. Research published in the Journal of Alzheimer’s Disease demonstrated that memantine treatment was associated with significant improvements in cognitive function and activities of daily living in patients with moderate to severe Alzheimer’s disease.

Additional Information

Memamed (memantine) coated tablets should be stored at room temperature away from moisture and heat. Keep out of reach of children.

Pharmacological Effects: Memantine works by blocking the action of glutamate, a neurotransmitter involved in learning and memory. By modulating glutamate levels, memantine helps regulate brain activity and improve cognitive function in Alzheimer’s patients.

Clinical Trials: Clinical trials have shown that memantine is well-tolerated and effective in managing symptoms of Alzheimer’s disease. A study published in the New England Journal of Medicine found that memantine treatment was associated with a slower decline in cognitive function and improved clinical global impression scores compared to placebo.